KnowledgeBase

• Home
• Antimicrobials
• Microorganisms
• About Us
• Contact Us

• Search All
• Search by Antimicrobial
• Search by Microorganism
• 

Home › Search by Microorganism › Staphylococcus haemolyticus (vancomycin-intermediate-susceptible)

• Staphylococcus haemolyticus
• Staphylococcus haemolyticus (8186366)
• Staphylococcus haemolyticus (ATCC 29970)
• Staphylococcus haemolyticus (clinical isolate)
• Staphylococcus haemolyticus (coagulase-negative + mupirocin-resistant)
• Staphylococcus haemolyticus (coagulase-negative + oxacillin-resistant)
• Staphylococcus haemolyticus (coagulase-negative + oxacillin-susceptible)
• Staphylococcus haemolyticus (coagulase-negative)
• Staphylococcus haemolyticus (GC 4547)
• Staphylococcus haemolyticus (LQC 5085)
• Staphylococcus haemolyticus (methicillin-resistant)
• Staphylococcus haemolyticus (methicillin-susceptible)
• Staphylococcus haemolyticus (oxacillin-resistant)
• Staphylococcus haemolyticus (oxacillin-susceptible)
• Staphylococcus haemolyticus (ST065 + coagulase-negative + teicoplanin-resistant)
• Staphylococcus haemolyticus (ST105 + coagulase-negative + teicoplanin-resistant)
• Staphylococcus haemolyticus (ST339 + coagulase-negative + teicoplanin-resistant)
• Staphylococcus haemolyticus (vancomycin-intermediate-susceptible)
• Staphylococcus haemolyticus (vancomycin-resistant)

This project is supported by TOKU-E which specializes in manufacturing ultra-pure antibiotics for a broad spectrum of biotechnology applications as well as for the pharmaceutical industry. TOKU-E is a global leader in biotechnology innovation, offering great benefits and applications to the biopharmaceutical and diagnostic industries as well as for biotechnology research communities.
Privacy Policy | Terms of Use
Knowledgebase version 1.8